Reliability of post-chemoradiotherapy F-18-FDG PET/CT for prediction of locoregional failure in human papillomavirus-associated oropharyngeal cancer

Oral Oncology

Volumn 50, Issue 3, 2014, Pages 234-239

  Vainshtein, Jeffrey M ^a   Spector, Matthew E ^b   Stenmark, Matthew H ^a   Bradford, Carol R ^b   Wolf, Gregory T ^b   Worden, Francis P ^b   Chepeha, Douglas B ^b   McHugh, Jonathan B ^b   Carey, Thomas ^b   Wong, Ka Kit ^b   Eisbruch, Avraham ^a  

^a Department of Radiation Oncology ^*  (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemoradiotherapy; Human papillomavirus; Metabolic response; PET surveillance; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCOREGIONAL FAILURE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; PET-CT SCANNER; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT RESPONSE;

CHEMORADIOTHERAPY; HUMAN PAPILLOMAVIRUS; METABOLIC RESPONSE; PET SURVEILLANCE; PET/CT;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893726405     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.12.003     Document Type: Article

References (21)

1. M. Hamoir, A. Ferlito, and S. Schmitz et al. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease Oral Oncol 48 3 2012 203 210
2. D.M. Brizel, R.G. Prosnitz, and S. Hunter et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 58 5 2004 1418 1423
3. G.L. Clayman, C.J. Johnson 2nd, W. Morrison, L. Ginsberg, and S.M. Lippman The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease Arch Otolaryngol Head Neck Surg 127 2 2001 135 139
4. T. Hehr, J. Classen, and U. Schreck et al. Selective lymph node dissection following hyperfractionated accelerated radio-(chemo-)therapy for advanced head and neck cancer Strahlenther Onkol 178 7 2002 363 368
5. V.S. Brkovich, F.R. Miller, A.B. Karnad, D.H. Hussey, H.S. McGuff, and R.A. Otto The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy Laryngoscope 116 6 2006 855 858
6. J.V. Nayak, R.R. Walvekar, and R.S. Andrade et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT Laryngoscope 117 12 2007 2129 2134
7. S.C. Ong, H. Schoder, and N.Y. Lee et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for Locoregional advanced head and neck cancer J Nucl Med 49 4 2008 532 540
8. S.V. Porceddu, D.I. Pryor, and E. Burmeister et al. Results of a prospective study of positron emission tomography-directed management of residual nodal abnormalities in node-positive head and neck cancer after definitive radiotherapy with or without systemic therapy Head Neck 33 12 2011 1675 1682
9. B.J. Moeller, V. Rana, and B.A. Cannon et al. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer J Clin Oncol 27 15 2009 2509 2515
10. M.G. Isles, C. McConkey, and H.M. Mehanna A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy Clin Otolaryngol 33 3 2008 210 222
11. D.M. Brizel, W. Lydiatt, and A.D. Colevas Controversies in the locoregional management of head and neck cancer J Natl Compr Canc Netw 9 6 2011 653 662
12. J.Y. Chan, G. Sanguineti, and J.D. Richmon et al. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma Arch Otolaryngol Head Neck Surg 138 11 2012 1040 1046
13. H. Quon, and A.A. Forastiere Controversies in treatment deintensification of human papillomavirus-associated oropharyngeal carcinomas: should we, how should we, and for whom? J Clin Oncol 31 5 2013 520 522
14. A.K. Chaturvedi, E.A. Engels, and R.M. Pfeiffer et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States J Clin Oncol 29 32 2011 4294 4301
15. A.L. Tang, S.J. Hauff, and J.H. Owen et al. UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line Head Neck 34 10 2012 1480 1491
16. L.H. Schwartz, J. Bogaerts, and R. Ford et al. Evaluation of lymph nodes with RECIST 1.1 Eur J Cancer 45 2 2009 261 267
17. S. Rohde, A.F. Kovacs, J. Berkefeld, and B. Turowski Reliability of CT-based tumor volumetry after intraarterial chemotherapy in patients with small carcinoma of the oral cavity and the oropharynx Neuroradiology 48 6 2006 415 421
18. P.D. Righi, D.J. Kelley, and R. Ernst et al. Evaluation of prevertebral muscle invasion by squamous cell carcinoma. Can computed tomography replace open neck exploration? Arch Otolaryngol Head Neck Surg 122 6 1996 660 663
19. T. Gupta, S. Jain, and J.P. Agarwal et al. Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation Radiother Oncol 97 2 2010 194 199
20. K.K. Ang, J. Harris, and R. Wheeler et al. Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 1 2010 24 35
21. D.I. Pryor, S.V. Porceddu, P.A. Scuffham, J.A. Whitty, P.A. Thomas, and B.H. Burmeister Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma Head Neck 35 9 2013 1287 1294